Filing Flows › Bausch Health Companies (BHC) › Q2 2026
Bausch Health Companies (BHC) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 30, 2026
Bausch Health Companies (BHC) reported revenue of $2.9B for the second quarter 2026 (Q2 2026), +13% from a year earlier and +13% from the quarter before. Operating margin was 25.9%, net earnings $258M (9.0% of revenue).
Bausch Health Companies, Q2 2026: revenue $2.9B (+13% year over year), operating margin 25.9%, net earnings $258M, operating cash flow $670M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.9B | +13% | +13% |
| Operating profit | $740M | — | +67% |
| Net earnings | $258M | — | +74% |
| Operating cash flow | $670M | +191% | +132% |
| Free cash flow | $593M | +390% | +212% |
What changed
Revenue was $2.9B in Q2 2026, up 13% year over year and up 13% from the previous quarter. Product sales was the largest line at 99% of revenue. Product sales added $0.32B year over year (up 13%), 100% of the total change.
Operating profit was $0.74B, a 25.9% margin (up 8.4 points year over year). Of the extra revenue versus Q2 2025, 92% reached operating profit, above the 18% margin then. Total costs grew 1% against revenue growth of 13%. Net earnings were $0.26B, up 74% year over year. The effective tax rate was 25.3%.
Operating cash flow was $0.67B (up 132% year over year), 258% of net earnings. Non-cash charges added back $0.28B of depreciation and amortization and $0.05B of share-based compensation. Working capital and other items added $0.07B. Capital expenditures of $0.08B left free cash flow of $0.59B.
Questions
What was Bausch Health Companies' revenue in the second quarter 2026?
Bausch Health Companies (BHC) reported revenue of $2.9B for the second quarter 2026 (Q2 2026), +13% from a year earlier and +13% from the quarter before.
Was Bausch Health Companies profitable in the second quarter 2026?
Operating profit was $740M (25.9% of revenue) and net earnings $258M.